NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/24/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization101.28 mln
Float6.00 mln
Earnings Date08/13/2026
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-3.08
Reliable
Relative Strength
83
/ 100
Strongly outperforming
Debt / Equity
0.44
Low leverage
Pre-Tax Margin
8%
Moderate margin
ROE
-1.88
Negative
Business Description
ImmuCell Corporation is a Maine-based animal health company that develops and sells products designed to improve the health and output of dairy and beef cattle across the United States and in other countries. Its core offerings help prevent and treat two major cattle health problems: scours, a common and potentially fatal digestive illness in calves, and mastitis, an udder infection that reduces milk quality and output in dairy cows. The company also has a treatment in development that uses a natural compound called Nisin to address a form of mastitis that shows no outward symptoms but still harms milk production. ImmuCell reaches its customers through animal health distributors and has been operating since 1982.